We begin this episode by discussing our article of the week from from the New England Journal of Medicine, entitled “Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.” In the second half, we have a conversation about Alzheimer's disease and how a drug called Donanemab has shown a 29% slower rate of decline and cognitive function. Next, we look at complications of bariatric surgery, the medical effects of heat exhaustion and what we can do to prevent it, and conclude with a conversation about energy drinks and it's lesser known side effects.